News
Scoping review of preclinical and clinical studies on the role of HMGB1 in heart disease - npj Cardiovascular Health
8+ hour, 47+ min ago (1737+ words) A potential novel therapeutic avenue for improving outcomes in cardiac disease involves targeting alarmins, endogenous danger signals capable of modulating both pathological inflammation and physiological repair9. Among these, High Mobility Group Box 1 (HMGB1) is the most extensively characterised9. HMGB1 can be actively secreted by…...
People with common problems 'have 35pc higher diabetes risk"
2+ hour, 37+ min ago (443+ words) Those experiencing loneliness, sleep difficulties and mental health conditions, including depression and anxiety, could face an elevated risk of developing type 2 diabetes, research indicates. The connection may be attributed to the body's reaction to chronic stress, scientists suggest. Behavioural and…...
Jiae Park of Joheungkang'an Hospital Achieves 9, 000 Pediatric Echocardiography Cases in 13 Years
5+ hour, 41+ min ago (118+ words) Published 09 Apr. 2026 16: 06(KST) Jiae Park, Head of the Department of Pediatrics at Joheungkang'an Hospital, has achieved 9, 000 pediatric echocardiography cases. On April 9, Joheungkang'an Hospital announced that Jiae Park had performed 9, 000 pediatric echocardiography cases over approximately 13 years, from May 2013 to March 2026. This…...
GLP-1s may reduce ED visits, infections and revisions for several orthopedic procedures
23+ min ago (236+ words) NEW ORLEANS " Results presented here showed GLP-1 receptor agonists may be associated with lower ED utilization and a reduction in surgical site infections and revisions for a range of orthopedic procedures. Researchers compared rates of ED presentation, surgical site infection…...
Hyperinsulinemia Emerges as Critical Predictor of Severe Liver Outcomes
27+ min ago (636+ words) Researchers have identified fasting hyperinsulinemia as a primary, yet often overlooked, driver of metabolic dysfunction-associated steatotic liver disease (MASLD). A new review published in Hepatology suggests that elevated insulin levels are not merely a symptom of metabolic syndrome but a…...
Ai system predicts masked hypertension using standard health data
50+ min ago (518+ words) Feels like: 12. 5 C12. 5 F | Partly cloudy High blood pressure is a major health concern affecting millions of people worldwide. It is closely linked to heart disease, stroke, and kidney problems. Many people rely on routine doctor visits to check their blood…...
Mounjaro monthly sales drop for first time in March, semaglutide gains volume- Moneycontrol. com
48+ min ago (247+ words) The reversal coincided with the mid'March launch of multiple branded semaglutide generics, which rapidly altered prescribing economics in the category. These products entered the market at significantly lower price points, immediately expanding patient access and triggering prescription switching away from…...
Ro is now selling Foundayo, a second daily oral GLP-1 alternative to injectable therapies
1+ hour, 32+ min ago (189+ words) Ro adds Lilly's Foundayo to its weight-loss options days after FDA approval. Ro is expanding its weight-loss offering with the addition of Eli Lilly's newly approved oral GLP-1, Foundayo (orforglipron), giving patients a second daily pill alternative to injectable therapies…...
New OCAN Survey: Majority of Eligible Older Americans View Coverage of GLP-1s as a Top Priority, yet 82% are Unaware of New Medicare Obesity Program
2+ hour, 47+ min ago (176+ words) The Joplin Globe - Download the Globe app to my phone or tablet WASHINGTON--(BUSINESS WIRE)--Apr 9, 2026-- Today, the Obesity Care Advocacy Network (OCAN) released new survey data revealing strong demand among older Americans for Medicare coverage of FDA-approved obesity medications…...
How Does the Complexity of Obesity Impact the Effectiveness of GLP-1s?
2+ hour, 42+ min ago (298+ words) Phenomix CEO Mark Bagnall discusses the effectiveness of GLP-1s and how obesity impacts different patients in a variety of complex ways. Clearly, the drugs are still popular. However, new data collected by Phenomix and the Mayo Clinic suggests that patients…...